Sleep Medicine Reviews
Volume 8, Issue 2 , Pages 133-148 , April 2004

Sleep in schizophrenia patients and the effects of antipsychotic drugs

  • Jaime M. Monti

      Affiliations

    • Department of Pharmacology and Therapeutics, Clinics Hospital, 2833/602 Zudanez Street, Montevideo 11300, Uruguay
    • Corresponding Author InformationCorresponding author. Tel.: +598-2-710-5807; fax: +598-2-487-2727
    • ,
  • Daniel Monti

      Affiliations

    • Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

References 

  1. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed.. Washington, DC: American Psychiatric Press; 1994;
  2. Jablensky A, Sartorius N, Ernberg G, et al.  Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl. 1992;20:1–97
  3. Van Kammen DP, van Kammen WB, Peters JL, et al.  CSF MHPG sleep and psychosis in schizophrenia. Clin Neuropharmacol. 1986;9(Suppl. 4):575–577
  4. American Sleep Disorders Association . International classification of sleep disorders, revised: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association; 1997;
  5. Carskadon MA, Dement WC. Normal human sleep: an overview. In:  Kryger MH,  Roth T,  Dement WC editor. Principles and practice of sleep medicine. Philadelphia: WB Saunders; 2000;p. 15–25 [chapter 2]
  6. Ganguli R, Reynolds CF, Kupfer DJ. Electroencephalographic sleep in young, never-medicated schizophrenics. Arch Gen Psychiatry. 1987;44:36–44
  7. Tandon R, Shipley JE, Taylor S, et al.  Electroencephalographic sleep abnormalities in schizophrenia. Arch Gen Psychiatry. 1992;49:185–194
  8. Lauer CJ, Schreiber W, Pollmächer T, et al.  Sleep in schizophrenia: a polysomnographic study on drug-naive patients. Neuropsychopharmacology. 1997;16:51–60
  9. Jus K, Bouchard M, Jus AK, et al.  Sleep EEG studies in untreated, long-term schizophrenic patients. Arch Gen Psychiatry. 1973;29:386–390
  10. Lauer CJ, Krieg JC. Slow-wave sleep and ventricular size: a comparative study in schizophrenia and major depression. Biol Psychiatry. 1998;44:121–128
  11. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages in human subjects. NIH Publ 204. Washington, DC: US Government Printing Office; 1968;
  12. Monti JM. Sleep laboratory and clinical studies of the effects of triazolam, flunitrazepam and flurazepam in insomniac patients. Meth Find Exptl Clin Pharmacol. 1981;3:303–326
  13. Keshavan MS, Reynolds CF, Miewald JM, et al.  Delta sleep deficits in schizophrenia. Arch Gen Psychiatry. 1998;55:443–448
  14. Hudson JI, Lipinski JF, Keck PE, et al.  Polysomnographic characteristics of schizophrenia in comparison with mania and depression. Biol Psychiatry. 1993;34:191–193
  15. Benson KL, Sullivan EV, Lim KO, et al.  Slow wave sleep and computed tomographic measures of brain morphology in schizophrenia. Psychiatry Res. 1996;60:125–134
  16. Hoffmann R, Hendrickse W, Rush AJ, et al.  Slow-wave activity during non-REM sleep in men with schizophrenia and major depressive disorders. Psychiatry Res. 2000;95:215–225
  17. Williams HL, Hammack JT, Daly RT, et al.  Responses to auditory stimulation, sleep loss, and the EEG stages of sleep. Electroenceph Clin Neurophysiol. 1964;16:269–275
  18. Dement W, Kleitman N. The relation of eye movements during sleep to dream activity: an objective method for the study of dreaming. J Exp Psychol. 1957;53:339–346
  19. Feinberg I, Koresko RL, Gottlieb F, et al.  Sleep electroencephalographic and eye-movement patterns in schizophrenic patients. Compr Psychiatry. 1964;5:44–53
  20. Feinberg I, Koresko RL, Gottlieb F. Further observations on electrophysiological sleep patterns in schizophrenia. Compr Psychiatry. 1965;6:21–24
  21. Feinberg I, Braun M, Koresko RL, et al.  Stage 4 sleep in schizophrenia. Arch Gen Psychiatry. 1969;21:263–266
  22. Caldwell DF, Domino EF. Electroencephalographic and eye movement patterns during sleep in chronic schizophrenic patients. Electroenceph Clin Neurophysiol. 1967;22:414–420
  23. Stern M, Fram DH, Wyatt R, et al.  All-night sleep studies of acute schizophrenics. Arch Gen Psychiatry. 1969;20:470–477
  24. Hiatt JF, Floyd TC, Katz PH, et al.  Further evidence of abnormal non-rapid-eye-movement sleep in schizophrenia. Arch Gen Psychiatry. 1985;42:797–802
  25. Zarcone VP, Benson KL, Berger PA. Abnormal rapid eye movement latencies in schizophrenia. Arch Gen Psychiatry. 1987;44:45–48
  26. Kempenaers C, Kerkhofs M, Linkowski P, et al.  Sleep EEG variables in young schizophrenic and depressive patients. Biol Psychiatry. 1988;24:833–838
  27. Benson KL, Faull KF, Zarcone VP. Evidence for the role of serotonin in the regulation of slow wave sleep in schizophrenia. Sleep. 1991;14:133–139
  28. Benson KL, Zarcone VP. Rapid eye movement sleep eye movements in schizophrenia and depression. Arch Gen Psychiatry. 1993;50:474–482
  29. Brannen JO, Jewett RE. Effects of selected phenothiazines on REM sleep in schizophrenics. Arch Gen Psychiatry. 1969;21:284–290
  30. Gillin C, Buchsbaum MS, Jacobs LS, et al.  Partial REM sleep deprivation, schizophrenia and field articulation. Arch Gen Psychiatry. 1974;30:653–662
  31. Reich L, Weiss BL, Coble P, et al.  Sleep disturbance in schizophrenia. Arch Gen Psychiatry. 1975;32:51–55
  32. Brambilla F, Scarone S, Pugnetti L, et al.  Bromocriptine therapy in chronic schizophrenia: effects of symptomatology, sleep patterns, and prolactine response to stimulation. Psychiatry Res. 1983;8:159–169
  33. van Kammen DP, van Kammen WB, Peters J, et al.  Decreased slow-wave sleep and enlarged lateral ventricles in schizophrenia. Neuropsychopharmacology. 1988;1:265–271
  34. Thaker GK, Wagman AMI, Tamminga CA. Sleep polygraphy in schizophrenia: methodological issues. Biol Psychiatry. 1990;28:240–246
  35. Taylor SF, Tandon R, Shipley JE, et al.  Sleep onset REM periods in schizophrenic patients. Biol Psychiatry. 1991;30:205–209
  36. Nofzinger EA, van Kammen DP, Gilbertson MW, et al.  Electroencephalographic sleep in clinically stable schizophrenic patients: two-weeks versus six-weeks neuroleptic free. Biol Psychiatry. 1993;33:829–835
  37. Zarcone VP, Benson KL. BPRS symptom factors and sleep variables in schizophrenia. Psychiatry Res. 1997;66:111–120
  38. Monti JM, Altier H. Flunitrazepam (RO 5-4200) and sleep in normal subjects. Psychopharmacologia. 1973;32:343–349
  39. Keshavan MS, Miewald J, Haas G, et al.  Slow-wave sleep and symptomatology in schizophrenia and related psychotic disorders. J Psychiat Res. 1995;29:303–314
  40. Kajimura N, Kato M, Okuma T, et al.  Relationship between delta activity during all-night sleep and negative symptoms in schizophrenia: a preliminary study. Biol Psychiatry. 1996;39:451–454
  41. Baldessarini RJ. Drugs for the treatment of psychiatric disorders. In:  Hardman JG,  Limbird LE editor. The pharmacological basis of therapeutics. New York: McGraw-Hill; 1996;p. 399–459 [chapter 18]
  42. Carlsson A, Lindquist M. Effects of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol. 1963;20:140–144
  43. Verhoeff NP. Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders. Psychopharmacology. 1999;147:217–249
  44. Laruelle M, Abi-Dargham A, van Dyck CH, et al.  Single photon emission computarized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA. 1996;93:9235–9240
  45. Breier A, Su TP, Saunders R, et al.  Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission topography method. Proc Natl Acad Sci USA. 1997;94:2569–2574
  46. Abi-Dargham A, Gil R, Krystal J, et al.  Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry. 1998;155:761–767
  47. Monti JM, Hawkins M, Jantos H, et al.  Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology. 1988;95:395–400
  48. Monti JM, Jantos H, Fernández M. Effects of the dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat. Eur J Pharmacol. 1989;169:61–66
  49. Dursun SM, Patel JKM, Burke JG, et al.  Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study. J Psychiatry Neurosci. 1999;24:333–337
  50. Sharpley AL, Vassallo CM, Cowen PJ. Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT2C receptors in vivo. Biol Psychiatry. 2000;47:468–470
  51. Sharpley AL, Vassallo CM, Pooley EC, et al.  Allelic variation in the 5-HT2C receptor (HT2RC) and the increase in slow wave sleep produced by olanzapine. Psychopharmacology. 2001;153:271–272
  52. Haffmans PMJ, Oolders JM, Hoencamp E, et al.  The effect of risperidone versus haloperidol on sleep patterns of schizophrenic patients: results of a double-blind, randomised pilot trial. Eur Neuropsychopharm. 2001;11(Suppl. 3):S260
  53. Bixler EO, Vgontzas AN, Kales A. Methodological issues in pharmacological studies of sleep. In:  Kales A editors. The pharmacology of sleep. Berlin: Springer; 1995;p. 323–343 [chapter 12]
  54. Taylor SF, Tandon R, Shipley JE, et al.  Effect of neuroleptic treatment on polysomnographic measures in schizophrenia. Biol Psychiatry. 1991;30:904–912
  55. Wetter TC, Lauer CJ, Gillich G, et al.  The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs. J psychiat Res. 1996;30:411–419
  56. Salin-Pascual RJ, Herrera-Estrella M, Galicia-Polo L, et al.  Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency. Biol Psychiatry. 1999;46:141–143
  57. Maixner S, Tandon R, Eiser A, et al.  Effects of antipsychotic treatment on polysomnographic measures in schizophrenia: a replication and extension. Am J Psychiatry. 1998;155:1600–1602
  58. Yamashita H, Morinobu S, Yamakawi S, et al.  Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. Psychiatry Res. 2002;109:137–142
  59. Touyz SW, Saayman GS, Zabow T. A psychophysiological investigation of the long-term effects of clozapine upon sleep patterns of normal young adults. Psychopharmacology. 1978;56:69–73
  60. Staedt J, Stoppe G, Hajak G, et al.  Rebound insomnia after abrupt clozapine withdrawal. Eur Arch Psychiatry Clin Neurosci. 1996;246:79–82
  61. Blin O. A comparative review of new antipsychotics. Can J Psychiatry. 1999;44:235–244
  62. Horácek J. Novel antipsychotics and extrapyramidal side effects. Theory and reality. Pharmacopsychiatry. 2000;33:34–42
  63. Stip E. Novel antipsychotics: issues and controversies. Typical and atypical antipsychotics. J Psychiatry Neurosci. 2000;25:137–153
  64. Kapur S, Remington G. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annu Rev Med. 2001;52:503–517
  65. Monti JM. Disturbances of sleep and wakefulness associated with the use of antihypertensive agents. Life Sci. 1987;41:1979–1988
  66. Heller-Brown J, Tylor P. Muscarinic receptor agonists and antagonists. In:  Hardman JG,  Limbird LE editor. The pharmacological basis of therapeutics. New York: McGraw-Hill; 1996;p. 141–160 [chapter 7]
  67. Monti JM, Monti D. Histamine H1 receptor antagonists in the treatment of insomnia. Is there a rational basis for use?. CNS Drugs. 2000;13:87–96
  68. Idzikowski C, Mills FJ, Glennard R. 5-Hydroxytryptamine-2-antagonist increases human slow wave sleep. Brain Res. 1986;378:164–168
  69. Idzikowski C, Cowen PJ, Nutt D, et al.  The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to L-tryptophan. Psychopharmacology. 1987;93:416–420
  70. Adam K, Oswald I. Effects of repeated ritanserin on middle-aged poor sleepers. Psychopharmacology. 1989;99:219–221
  71. Ruiz-Primo E, Haro R, Valencia M. Polysomnographic effects of ritanserin in insomniacs: a crossed double-blind controlled study. Sleep Res. 1989;18:72
  72. Katsuda Y, Walsh AES, Ware CJ, et al.  meta-Chlorophenylpiperazine decreased slow wave sleep in humans. Biol Psychiatry. 1993;33:49–51
  73. Sharpley AL, Elliot JM, Attenburrow MJ, et al.  Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors. Neuropharmacology. 1994;33:467–471
  74. Hinze-Selch D, Mullington J, Orth A, et al.  Effects of clozapine on sleep: a longitudinal study. Biol Psychiatry. 1997;42:260–266

PII: S1087-0792(02)00158-2

doi: 10.1016/S1087-0792(02)00158-2

Sleep Medicine Reviews
Volume 8, Issue 2 , Pages 133-148 , April 2004

Article Tools